Villejust, France

Andre Malanda

USPTO Granted Patents = 17 

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 100(Granted Patents)


Location History:

  • Paris, FR (2010 - 2012)
  • Antony, FR (2012)
  • Villejust, FR (2008 - 2014)

Company Filing History:


Years Active: 2008-2014

Loading Chart...
17 patents (USPTO):Explore Patents

Title: Andre Malanda: Innovator in Therapeutic Compounds

Introduction

Andre Malanda is a notable inventor based in Villejust, France. He has made significant contributions to the field of therapeutic compounds, holding a total of 17 patents. His work focuses on innovative chemical compounds that have potential applications in medicine.

Latest Patents

Among his latest patents, one notable invention is titled "N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives." This invention concerns compounds of general formula (I), wherein n, X, Y, and W are defined within the patent. The invention also outlines a method for preparing these compounds and their therapeutic use. Another significant patent relates to compounds of the general formula (I), detailing a method for their preparation and therapeutic applications.

Career Highlights

Throughout his career, Andre Malanda has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his innovative ideas in therapeutic compounds.

Collaborations

Andre has collaborated with several professionals in his field, including Laurent Dubois and Yannick Evanno. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Andre Malanda's contributions to the field of therapeutic compounds are noteworthy, with a solid portfolio of patents that reflect his innovative spirit. His work continues to influence the pharmaceutical industry and offers promising avenues for future research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…